Cited by 94Liver Disease Diagnosis and TreatmentPhysical Activity and HealthCardiovascular and exercise physiology

Improvement in histological endpoints of MAFLD following a 12-week aerobic exercise intervention

O’Gorman, Philip, Naimimohasses, Sara, Monaghan, Ann, Kennedy, Megan, Melo, Ashanty M., Ní Fhloinn, Deirdre, Doherty, Derek G., Beddy, Peter +4 more·2020·Alimentary Pharmacology & Therapeutics

Abstract

Summary Background Lifestyle interventions are the primary treatment for metabolic (dysfunction) associated fatty liver disease (MAFLD). However, the histological and cardiometabolic effects of aerobic exercise in MAFLD remain unclear. Aims To assess the effects of a 12‐week aerobic exercise intervention on histological and cardiometabolic endpoints in MAFLD. Methods Patients with biopsy‐confirmed MAFLD participated in a 12‐week aerobic exercise intervention. Liver histology, cardiorespiratory fitness (estimated V̇O 2max ), physical activity, anthropometry and biochemical markers were assessed at baseline, intervention completion, and 12 and 52 weeks after intervention completion. Results Twenty‐four patients completed the exercise intervention (exercise group n = 16, control group n = 8). In the exercise group, 12 weeks of aerobic exercise reduced fibrosis and hepatocyte ballooning by one stage in 58% ( P = 0.034) and 67% ( P = 0.020) of patients, with no changes in steatosis ( P = 1.000), lobular inflammation ( P = 0.739) or NAFLD activity score ( P = 0.172). Estimated V̇O 2max increased by 17% compared to the control group ( P = 0.027) but this level of improvement was not maintained at 12 or 52 weeks after the intervention. Patients with fibrosis and ballooning improvement increased estimated V̇O 2max by 25% ( P = 0.020) and 26% ( P = 0.010), respectively. Anthropometric reductions including body mass ( P = 0.038), waist circumference ( P = 0.015) and fat mass ( P = 0.007) were also observed, but no patient achieved 7%‐10% weight loss. Conclusion This study highlights the potential benefits of a 12‐week aerobic exercise intervention in improving histological endpoints of MAFLD. The development of strategies to ensure continued engagement in aerobic exercise in MAFLD are needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/apt.15989

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Should patients continue to complete guideline-based amounts of aerobic exercise over a longer duration, fibrosis improvement may follow.

    “Based on this, it seems reasonable to conclude that should patients continue to complete guideline-based amounts of aerobic exercise over a longer duration, fibrosis improvement may follow [35, 36].”

    From Aerobic Exercise Training Leads to MASH Resolution as Defined by the MASH Resolution Index (2026) · cites this paper as [36]

    The Results report fibrosis improvement after a 12-week aerobic exercise intervention, and the Conclusions say the benefits were not sustained at one year without continued prescribed exercise. These findings support the possibility that continued exercise could help, but the paper does not establish that guideline-based amounts over a longer duration would produce fibrosis improvement; that is the citing authors’ extrapolation. (LLM, conf=0.83)

    Experimental — accuracy not yet measured
  • Owing to limited clinical trial data, it is currently unclear whether exercise training can independently improve liver histology.

    “Owing to limited clinical trial data, it is currently unclear whether exercise training can independently improve liver histology. 318,319”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
O’Gorman, P., Naimimohasses, S., Monaghan, A., Kennedy, M., Melo, A. M., Ní Fhloinn, D., Doherty, D. G., Beddy, P., Finn, S. P., Moore, J. B., Gormley, J., & Norris, S.
Affiliations
  • Trinity College Dublin (IE)
  • Department of Hepatology St James’s Hospital Dublin Ireland
  • St. James's Hospital (IE)
  • University of Leeds (GB)
Corresponding author
O’Gorman, Philip
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
2020-07-27
Volume
52
Issue
8
Pages
1387-1398
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W3045799557
Cited by
94
References
53
Citations by year
2026: 11 · 2025: 12 · 2024: 21 · 2023: 15 · 2022: 16 · 2021: 15 · 2020: 4
FWCI
8.96
Type
journal article
Language
en
Open access
closed
Locations
  • Alimentary Pharmacology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
  • Arrow@dit (Dublin Institute of Technology) (acceptedVersion)
  • Trinity's Access to Research Output (TARA) (Trinity College Dublin) (submittedVersion)
Funders
Health Research Board (HRA‐POR‐2015‐1185)
Topics
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Physiology › Physical Activity and Health
  • Health Sciences › Medicine › Complementary and alternative medicine › Cardiovascular and exercise physiology
Keywords
non-alcoholic fatty liver disease, aerobic exercise, liver histopathology, liver fibrosis, hepatocyte ballooning, cardiorespiratory fitness, NAFLD activity score, steatosis, cardiometabolic effects, lifestyle intervention, weight loss
MeSH terms
Adult, Aged, Biopsy, Body Composition, Exercise Therapy, Female, Humans, Ireland, Liver, Male, Middle Aged, Weight Loss, Exercise, Treatment Outcome, Waist Circumference, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review